Transactions

TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

$28.8 M
IPO

Sole Book-Runner

OMNIQ Corp.

OMNIQ Corp.

$15 M
Private Placement

Sole Placement Agent

Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc.

$40 M
Follow-On Offering

Sole Book-Runner

cbdMD, Inc.

cbdMD, Inc.

$16.5 M
8% Series A Cumulative Convertible Preferred Stock

Sole Book-Runner

Second Sight Medical Products, Inc.

Second Sight Medical Products, Inc.

$57.5 M
Follow-On Offering

Sole Book-Runner

FAT Brands Inc.

FAT Brands Inc.

$9.2 M
8.25% Series B Cumulative Preferred Stock

Sole Book-Runner

iSpecimen Inc.

iSpecimen Inc.

$20.7 M
IPO

Sole Book-Runner

Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc.

$45 M
Follow-On Offering

Sole Book-Runner

Harbor Custom Development, Inc.

Harbor Custom Development, Inc.

$31.5 M
8% Series A Cumulative Convertible Preferred Stock

Sole Book-Runner

BK Technologies Corporation

BK Technologies Corporation

$12.8 M
Follow-On Offering

Sole Book-Runner

BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

$27.2 M
Private Placement

Sole Placement Agent

1847 Goedeker Inc.

1847 Goedeker Inc.

$70 M
Debt Financing

Sole Placement Agent